Removal of fistula tract feasible without harming the sphincter – fast recovery and convincing results – more information at info-analfistel.de/en
Jena, July 9, 2014 – Surgery of anal fistula successful, patient incontinent. Those affected often have to face this bitter truth after a surgical procedure. Despite medicals taking highest caution and effort when splitting the anal fistula, „rectal incontinence“ is unfortunately a common finding after surgery. The bigger the sphincter mass that lies beneath the fistula, the higher the risk. Even though the sphincter can be stitched, this suture can loosen over time. The result is rectal incontinence, meaning bowel movements and winds cannot be wilfully withhold.
Hence patients are often looking for a therapy which removes anal fistulas effectively and as painlessly as possible, which shortens the period of recovery, but which also strongly considers the preservation of continence. These demands are especially met by modern laser therapy FiLaC®. The pioneering medical LEONARDO® laser and the innovative laser probe by biolitec® achieve excellent results in the removal of anal fistulas.
Laser light and slowly withdrawing the probe close the anal fistula like a zipper. The laser treatment takes only a few minutes and opens up the possibility to completely spare the enucleation of the fistula from healthy tissue. The specially designed laser probe is very flexible and can be applied no matter what the length of the fistula tract is. The limited penetration depth of the laser light is highly muscle-protecting, but still effective enough to close the fistula.
As a result, the sphincter remains untouched. The innovative laser treatment FiLaC® does not involve a scalpel. Surgery of anal fistulas successful, patient satisfied.
About biolitec:
biolitec AG is one of the leading companies worldwide in the field of medical laser treatments and the only provider that possesses all relevant core competencies – photosensitizers, laser devices and optical fibers – in the field of photodynamic therapy (PDT). Besides laser-based treatment of cancer with the drug Foscan®, biolitec AG primarily researches on minimally-invasive and gentle laser treatments and markets them. ELVeS Radial™ (Endo Laser Vein System) is the most often used laser system worldwide for the treatment of varicose veins. In combination with the Ceralas® HPD laser, the innovative contact fiber XCAVATOR™ enables a gentle treatment of e.g. benign prostatic hyperplasia (BPH) in urology. The new LEONARDO® diode laser by biolitec® is the first universally applicable medical laser which features a combination of two wavelengths, 980nm and 1470nm, and is suitable for interdisciplinary use. Gentle laser treatments in the fields of proctology, ENT, gynecology, thoracic surgery as well as pneumology also belong to the business field of biolitec AG. Further information at www.biolitec.com.
biolitec AG
Jörn Gleisner
Otto-Schott-Straße 15
07745 Jena
+49 (0) 3641/5195336
joern.gleisner@biolitec.com
http://www.biolitec.de